ROYSTON IVOR has filed 9 insider transactions across 1 company since February 2024.
Most recent transaction: a option exercise of 25219 shares of Viracta Therapeutics, Inc. ($VIRX) on November 25, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 25, 2024 | Viracta Therapeutics, Inc. | $VIRX | ROYSTON IVOR | Not found | M | Common Stock | 25219 | $0.00 | 858,340.0000 | 39,744,222 | 3.03% | 0.06% |
| Nov. 25, 2024 | Viracta Therapeutics, Inc. | $VIRX | ROYSTON IVOR | Not found | M | Restricted Stock Units | 25219 | $0.00 | 50,438.0000 | 39,744,222 | 33.33% | 0.06% |
| Aug. 25, 2024 | Viracta Therapeutics, Inc. | $VIRX | ROYSTON IVOR | Not found | M | Common Stock | 25219 | $0.00 | 833,121.0000 | 39,272,434 | 3.12% | 0.06% |
| Aug. 25, 2024 | Viracta Therapeutics, Inc. | $VIRX | ROYSTON IVOR | Not found | M | Restricted Stock Units | 25219 | $0.00 | 75,657.0000 | 39,272,434 | 25.00% | 0.06% |
| June 20, 2024 | Viracta Therapeutics, Inc. | $VIRX | ROYSTON IVOR | Not found | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 39,272,434 | 9999.99% | 0.13% |
| May 25, 2024 | Viracta Therapeutics, Inc. | $VIRX | ROYSTON IVOR | Not found | M | Common Stock | 25219 | $0.00 | 807,902.0000 | 39,272,434 | 3.22% | 0.06% |
| May 25, 2024 | Viracta Therapeutics, Inc. | $VIRX | ROYSTON IVOR | Not found | M | Restricted Stock Units | 25219 | $0.00 | 100,876.0000 | 39,272,434 | 20.00% | 0.06% |
| Feb. 25, 2024 | Viracta Therapeutics, Inc. | $VIRX | ROYSTON IVOR | Director | M | Common Stock | 25219 | $0.00 | 782,683.0000 | 0 | 3.33% | 0.00% |
| Feb. 25, 2024 | Viracta Therapeutics, Inc. | $VIRX | ROYSTON IVOR | Director | M | Restricted Stock Units | 25219 | $0.00 | 126,095.0000 | 0 | 16.67% | 0.00% |